Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of Super Transplantation in the Treatment of Severe β-thalassemia

NCT06734520 is registered in ClinicalTrials.gov with Guangzhou Women and Children's Medical Center as lead sponsor.

NCT NCT06734520
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06734520 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of Super Transplantation in the Treatment of Severe β-thalassemia
Lead sponsor
Guangzhou Women and Children's Medical Center
Phase
Not applicable
Overall status
Recruiting
Start date
October 1, 2024
Completion date
July 1, 2029
Enrollment
3 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

haplo-identical donors, thalassemia majors (beta-thalassemia major)